Insmed, Inc. (INSM) Misses Q3 EPS by 5c as Costs Rise
Insmed, Inc. (NASDAQ: INSM) reported Q3 EPS of ($0.46), $0.05 worse than the analyst estimate of ($0.41). Revenue for the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
